{"id":291239,"date":"2026-10-07T09:44:49","date_gmt":"2026-10-07T04:14:49","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=291239"},"modified":"2026-10-07T09:44:49","modified_gmt":"2026-10-07T04:14:49","slug":"medicamen-biotech-vs-nifty-50-share-price-performance","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-nifty-50-share-price-performance\/","title":{"rendered":"Medicamen Biotech vs Nifty 50: Share Price Performance Compared"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Medicamen Biotech share price Rs 311.95 on NSE. Medicamen Biotech vs Nifty 50 over 1 year: +5.05% vs -9.29%. 52-week high Rs 447.65, low Rs 212.40.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Medicamen Biotech vs Nifty 50 shows Medicamen Biotech ahead of the benchmark on a one-year view, gaining +5.05% against the Nifty 50&#8217;s -9.29%. Over the longer term the index has pulled ahead, a reminder that short-term outperformance does not always hold up over multi-year horizons. Investors comparing the two should also weigh Medicamen Biotech&#8217;s trading liquidity, valuation and sector context rather than relying on returns alone.<\/p>\n<\/div>\n<p>Medicamen Biotech vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Medicamen Biotech trades on the NSE under the symbol MEDICAMEQ, and its 1M return of +11.71% compares with the Nifty 50&#8217;s -4.22% over the same period.<\/p>\n<p>The Medicamen Biotech vs Nifty 50 comparison matters because Medicamen Biotech is a single stock exposed to its own sector and company-specific developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Medicamen Biotech share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year, 3 years, using NSE closing data.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/mas-financial-services-vs-nifty-50-share-price-performance\">MAS Financial Services vs Nifty 50: Returns Compared<\/a><\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=medicameq-vs-nifty50\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-nifty-50-share-price-performance\/#Medicamen_Biotech_vs_Nifty_50_Performance_at_a_Glance\" title=\"Medicamen Biotech vs Nifty 50: Performance at a Glance\">Medicamen Biotech vs Nifty 50: Performance at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-nifty-50-share-price-performance\/#Why_the_Medicamen_Biotech_vs_Nifty_50_Gap_Exists\" title=\"Why the Medicamen Biotech vs Nifty 50 Gap Exists\">Why the Medicamen Biotech vs Nifty 50 Gap Exists<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-nifty-50-share-price-performance\/#Medicamen_Biotech_vs_Nifty_50_Has_Medicamen_Biotech_Beaten_the_Benchmark\" title=\"Medicamen Biotech vs Nifty 50: Has Medicamen Biotech Beaten the Benchmark?\">Medicamen Biotech vs Nifty 50: Has Medicamen Biotech Beaten the Benchmark?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-nifty-50-share-price-performance\/#Risks_of_the_Medicamen_Biotech_vs_Nifty_50_Comparison\" title=\"Risks of the Medicamen Biotech vs Nifty 50 Comparison\">Risks of the Medicamen Biotech vs Nifty 50 Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-nifty-50-share-price-performance\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-nifty-50-share-price-performance\/#Has_Medicamen_Biotech_outperformed_the_Nifty_50_in_the_last_year\" title=\"Has Medicamen Biotech outperformed the Nifty 50 in the last year?\">Has Medicamen Biotech outperformed the Nifty 50 in the last year?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-nifty-50-share-price-performance\/#How_does_Medicamen_Biotech_vs_Nifty_50_look_over_3_years\" title=\"How does Medicamen Biotech vs Nifty 50 look over 3 years?\">How does Medicamen Biotech vs Nifty 50 look over 3 years?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-nifty-50-share-price-performance\/#What_is_the_Medicamen_Biotech_share_price_today_compared_to_Nifty_50\" title=\"What is the Medicamen Biotech share price today compared to Nifty 50?\">What is the Medicamen Biotech share price today compared to Nifty 50?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-nifty-50-share-price-performance\/#What_is_the_52-week_high_and_low_of_Medicamen_Biotech\" title=\"What is the 52-week high and low of Medicamen Biotech?\">What is the 52-week high and low of Medicamen Biotech?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-nifty-50-share-price-performance\/#Why_does_Medicamen_Biotech_show_bigger_price_swings_than_the_Nifty_50\" title=\"Why does Medicamen Biotech show bigger price swings than the Nifty 50?\">Why does Medicamen Biotech show bigger price swings than the Nifty 50?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-nifty-50-share-price-performance\/#Is_Medicamen_Biotech_a_good_long-term_investment_compared_to_a_Nifty_50_index_fund\" title=\"Is Medicamen Biotech a good long-term investment compared to a Nifty 50 index fund?\">Is Medicamen Biotech a good long-term investment compared to a Nifty 50 index fund?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Medicamen_Biotech_vs_Nifty_50_Performance_at_a_Glance\"><\/span><strong>Medicamen Biotech vs Nifty 50: Performance at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets out Medicamen Biotech vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 7 October 2026.<\/p>\n<table border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th>Time Frame<\/th>\n<th>Medicamen Biotech Return<\/th>\n<th>Nifty 50 Return<\/th>\n<th>Difference<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1 Month<\/td>\n<td>+11.71%<\/td>\n<td>-4.22%<\/td>\n<td>+15.93% pp<\/td>\n<\/tr>\n<tr>\n<td>3 Months<\/td>\n<td>+24.13%<\/td>\n<td>-4.63%<\/td>\n<td>+28.77% pp<\/td>\n<\/tr>\n<tr>\n<td>6 Months<\/td>\n<td>+29.63%<\/td>\n<td>-5.09%<\/td>\n<td>+34.72% pp<\/td>\n<\/tr>\n<tr>\n<td>1 Year<\/td>\n<td>+5.05%<\/td>\n<td>-9.29%<\/td>\n<td>+14.34% pp<\/td>\n<\/tr>\n<tr>\n<td>3 Years<\/td>\n<td>-51.61% (<a href=\"https:\/\/univest.in\/stocks\/medicameq\/medicamen-biotech-ltd-share-price-today\">Medicamen Biotech<\/a>)<\/td>\n<td>+15.89% (<a href=\"https:\/\/univest.in\/indices\/nifty-50\/nifty-50-share-price-today\">Nifty 50<\/a>)<\/td>\n<td>-67.5% pp<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>On the Medicamen Biotech vs Nifty 50 scorecard, Medicamen Biotech has stayed ahead of the index over the most recent one-year window. Over the longer term the index has pulled ahead, a reminder that short-term outperformance does not always hold up over multi-year horizons.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live Medicamen Biotech and Nifty 50 data<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_the_Medicamen_Biotech_vs_Nifty_50_Gap_Exists\"><\/span><strong>Why the Medicamen Biotech vs Nifty 50 Gap Exists<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Medicamen Biotech&#8217;s stock can move quite differently from the Nifty 50 because it carries concentrated exposure to its own sector and business cycle, unlike the index which blends 50 companies across banking, IT, energy and consumer sectors. This is the main driver of the gap seen in the Medicamen Biotech vs Nifty 50 return table above.<\/p>\n<p>A second factor behind the Medicamen Biotech vs Nifty 50 divergence is valuation and trading liquidity. Company-specific news, quarterly results and sector sentiment can move Medicamen Biotech&#8217;s price sharply in either direction over short periods, while the Nifty 50&#8217;s return reflects the blended earnings trajectory of its constituents and is far less exposed to any single stock&#8217;s swings.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Medicamen Biotech and Nifty 50 live on the go.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Medicamen_Biotech_vs_Nifty_50_Has_Medicamen_Biotech_Beaten_the_Benchmark\"><\/span><strong>Medicamen Biotech vs Nifty 50: Has Medicamen Biotech Beaten the Benchmark?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Medicamen Biotech has beaten the Nifty 50 over the past year, gaining +5.05% against the index&#8217;s -9.29% over the same period.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/max-estates-vs-nifty-50-share-price-performance\">Max Estates vs Nifty 50: Share Price Performance Compared<\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks_of_the_Medicamen_Biotech_vs_Nifty_50_Comparison\"><\/span><strong>Risks of the Medicamen Biotech vs Nifty 50 Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Reading too much into a Medicamen Biotech vs Nifty 50 comparison has real limitations that investors should weigh before drawing conclusions. Medicamen Biotech carries concentrated business and sector risk that a diversified index does not, and its trading volumes and price swings can differ meaningfully from the Nifty 50&#8217;s more liquid, blended profile. A stock&#8217;s 52-week range of Rs 212.40 to Rs 447.65 also shows the kind of volatility that a single-stock investment carries relative to a broad index.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Medicamen Biotech vs Nifty 50 highlights how a single stock&#8217;s return path can differ from a diversified benchmark over different time horizons. Investors weighing the Medicamen Biotech vs Nifty 50 record should factor in Medicamen Biotech&#8217;s volatility, liquidity and sector concentration alongside its return history, and consult a SEBI-registered advisor before making an allocation decision.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h3><span class=\"ez-toc-section\" id=\"Has_Medicamen_Biotech_outperformed_the_Nifty_50_in_the_last_year\"><\/span><strong>Has Medicamen Biotech outperformed the Nifty 50 in the last year?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes. Medicamen Biotech gained +5.05% over the past year while the Nifty 50 returned -9.29% over the same period, based on NSE closing prices to 7 October 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Medicamen_Biotech_vs_Nifty_50_look_over_3_years\"><\/span><strong>How does Medicamen Biotech vs Nifty 50 look over 3 years?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Over three years Medicamen Biotech has returned -51.61% compared with the Nifty 50&#8217;s +15.89%, so in the Medicamen Biotech vs Nifty 50 comparison the index has been ahead over this horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Medicamen_Biotech_share_price_today_compared_to_Nifty_50\"><\/span><strong>What is the Medicamen Biotech share price today compared to Nifty 50?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Medicamen Biotech share price stood at Rs 311.95 on NSE, while the Nifty 50 traded at 22,776.10 based on the same closing data window.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52-week_high_and_low_of_Medicamen_Biotech\"><\/span><strong>What is the 52-week high and low of Medicamen Biotech?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Medicamen Biotech&#8217;s 52-week high is Rs 447.65 and its 52-week low is Rs 212.40, based on NSE data.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_does_Medicamen_Biotech_show_bigger_price_swings_than_the_Nifty_50\"><\/span><strong>Why does Medicamen Biotech show bigger price swings than the Nifty 50?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Medicamen Biotech carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies, so company-specific news moves Medicamen Biotech&#8217;s price more sharply than the diversified index, a key reason the Medicamen Biotech vs Nifty 50 return gap varies across time frames.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Medicamen_Biotech_a_good_long-term_investment_compared_to_a_Nifty_50_index_fund\"><\/span><strong>Is Medicamen Biotech a good long-term investment compared to a Nifty 50 index fund?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Medicamen Biotech&#8217;s suitability depends on an investor&#8217;s risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund; long-term investors should weigh the Medicamen Biotech vs Nifty 50 return history alongside the company&#8217;s fundamentals and consult a SEBI-registered advisor.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Has Medicamen Biotech outperformed the Nifty 50 in the last year?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes. Medicamen Biotech gained +5.05% over the past year while the Nifty 50 returned -9.29% over the same period, based on NSE closing prices to 7 October 2026.\"}},{\"@type\":\"Question\",\"name\":\"How does Medicamen Biotech vs Nifty 50 look over 3 years?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Over three years Medicamen Biotech has returned -51.61% compared with the Nifty 50's +15.89%, so in the Medicamen Biotech vs Nifty 50 comparison the index has been ahead over this horizon.\"}},{\"@type\":\"Question\",\"name\":\"What is the Medicamen Biotech share price today compared to Nifty 50?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Medicamen Biotech share price stood at Rs 311.95 on NSE, while the Nifty 50 traded at 22,776.10 based on the same closing data window.\"}},{\"@type\":\"Question\",\"name\":\"What is the 52-week high and low of Medicamen Biotech?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Medicamen Biotech's 52-week high is Rs 447.65 and its 52-week low is Rs 212.40, based on NSE data.\"}},{\"@type\":\"Question\",\"name\":\"Why does Medicamen Biotech show bigger price swings than the Nifty 50?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Medicamen Biotech carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies, so company-specific news moves Medicamen Biotech's price more sharply than the diversified index, a key reason the Medicamen Biotech vs Nifty 50 return gap varies across time frames.\"}},{\"@type\":\"Question\",\"name\":\"Is Medicamen Biotech a good long-term investment compared to a Nifty 50 index fund?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Medicamen Biotech's suitability depends on an investor's risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund; long-term investors should weigh the Medicamen Biotech vs Nifty 50 return history alongside the company's fundamentals and consult a SEBI-registered advisor.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>How does Medicamen Biotech compare to the Nifty 50? See share price performance, returns and key data points.<\/p>\n","protected":false},"author":35,"featured_media":291238,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[708,1019],"class_list":["post-291239","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-nifty-50","tag-stock-market"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["291238"],"rank_math_title":["Medicamen Biotech vs Nifty 50: Share Price Performance Compared"],"rank_math_description":["See how Medicamen Biotech share price has performed against the Nifty 50 across multiple time frames, with returns compared side by side using NSE closing data."],"rank_math_focus_keyword":["Medicamen Biotech vs Nifty 50"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/medicamen-biotech-vs-nifty-50-share-price-performance-compared.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/291239","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=291239"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/291239\/revisions"}],"predecessor-version":[{"id":291240,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/291239\/revisions\/291240"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/291238"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=291239"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=291239"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=291239"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}